Prognostic Factors for Combined Ranibizumab and Prompt Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy.
Sign Up to like & getrecommendations! Published in 2019 at "Photodiagnosis and photodynamic therapy"
DOI: 10.1016/j.pdpdt.2019.06.004
Abstract: PURPOSE To investigate the prognostic factors for the combined therapy of ranibizumab and prompt verteporfin photodynamic therapy (vPDT) for eyes with polypoidal choroidal vasculopathy (PCV). METHODS Sixty-two PCV eyes of 62 patients that received the… read more here.
Keywords: photodynamic therapy; prognostic factors; factors combined; therapy ... See more keywords
Natural History and Risk Factor of Recurrent Hemorrhage in Hemorrhagic Adult Moyamoya Disease
Sign Up to like & getrecommendations! Published in 2017 at "Neurosurgery"
DOI: 10.1093/neuros/nyw179
Abstract: BACKGROUND Recurrent hemorrhage is a serious neurosurgical problem in adult moyamoya disease (MMD) patients. OBJECTIVE To find the natural history and risk factors of recurrent hemorrhage in cases of adult hemorrhagic MMD. METHODS One hundred… read more here.
Keywords: risk; adult; hemorrhagic; hemorrhage ... See more keywords